Clinical Trial Update: Intensive Cholesterol-Lowering and CD8+ T Cells in Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial from Cedars-Sinai Medical Center is evaluating intensive cholesterol-lowering together with CD8+ T cell–related strategies in patients …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Prostate Cancer | Phase 2 | Status: RECRUITING